We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENV
1376
DELISTED
ENVESTNET, INC.
ENV
| $11.6M | ﹤0.01% |
261,127
-4,498
| -2% | -$240K |
|
1377
Beam Therapeutics
BEAM
$2.84B
| $11.6M | ﹤0.01% |
242,957
+13,491
| +6% | +$770K |
|
1378
Tanger
SKT
$4.52B
| $11.5M | ﹤0.01% |
843,698
+919
| +0.1% | +$14.3K |
|
1379
Customers Bancorp
CUBI
$2.77B
| $11.5M | ﹤0.01% |
390,778
+142
| +0% | +$5.03K |
|
|
RCM
1380
DELISTED
R1 RCM Inc. Common Stock
RCM
| $11.5M | ﹤0.01% |
621,180
-420,987
| -40% | -$9.6M |
|
1381
Affiliated Managers Group
AMG
$9.76B
| $11.5M | ﹤0.01% |
102,737
-5,284
| -5% | -$663K |
|
|
GOLD
1382
Gold.com Inc
GOLD
$1.26B
| $11.5M | ﹤0.01% |
403,516
+163,092
| +68% | +$4.96M |
|
1383
Harmonic Inc
HLIT
$1.28B
| $11.4M | ﹤0.01% |
870,994
+490,810
| +129% | +$5.3M |
|
|
SP
1384
DELISTED
SP Plus Corporation
SP
| $11.4M | ﹤0.01% |
362,623
-124,998
| -26% | -$4.13M |
|
1385
Blue Owl Capital
OWL
$18.5B
| $11.4M | ﹤0.01% |
1,229,942
+415,113
| +51% | +$4.61M |
|
|
FL
1386
DELISTED
Foot Locker
FL
| $11.3M | ﹤0.01% |
364,048
-95,516
| -21% | -$3.05M |
|
|
DISH
1387
DELISTED
DISH Network Corp.
DISH
| $11.3M | ﹤0.01% |
819,150
-6,101
| -0.7% | -$108K |
|
1388
AGNC Investment
AGNC
$12.9B
| $11.3M | ﹤0.01% |
1,344,763
-13,142
| -1% | -$154K |
|
1389
Alpha Metallurgical Resources
AMR
$1.93B
| $11.3M | ﹤0.01% |
82,675
+19,934
| +32% | +$2.77M |
|
1390
Establishment Labs
ESTA
$2.28B
| $11.3M | ﹤0.01% |
207,045
-1,767
| -0.8% | -$106K |
|
|
MODV
1391
DELISTED
ModivCare
MODV
| $11.3M | ﹤0.01% |
113,417
+15,544
| +16% | +$1.61M |
|
1392
National Vision
EYE
$1.81B
| $11.3M | ﹤0.01% |
345,337
-23,447
| -6% | -$762K |
|
1393
Signet Jewelers
SIG
$3.76B
| $11.3M | ﹤0.01% |
197,133
-5,770
| -3% | -$347K |
|
1394
TaskUs
TASK
$669M
| $11.2M | ﹤0.01% |
697,733
+167,102
| +31% | +$2.95M |
|
1395
Andersons Inc
ANDE
$2.22B
| $11.2M | ﹤0.01% |
361,594
+24,682
| +7% | +$858K |
|
|
NXGN
1396
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $11.2M | ﹤0.01% |
633,157
-198,309
| -24% | -$3.44M |
|
1397
Hims & Hers Health
HIMS
$7.31B
| $11.2M | ﹤0.01% |
2,001,695
+1,501,568
| +300% | +$9.05M |
|
|
EWCZ
1398
DELISTED
European Wax Center
EWCZ
| $11.2M | ﹤0.01% |
604,501
-16,937
| -3% | -$333K |
|
1399
Ingredion
INGR
$6.58B
| $11.1M | ﹤0.01% |
137,429
-61,588
| -31% | -$5.4M |
|
|
CSII
1400
DELISTED
Cardiovascular Systems, Inc.
CSII
| $11.1M | ﹤0.01% |
798,142
-6,246
| -0.8% | -$92.8K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.